Eversept Partners »

Ultragenyx Pharmaceutical shares owned by Eversept Partners

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.3M 317k 23.00

More positions owned by Eversept Partners

Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
GSK Sponsored Adr (GSK)
United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Miragen Therapeutics (VRDN)
Vaxcyte (PCVX)
Travere Therapeutics (TVTX)
Hca Holdings (HCA)
Danaher Corporation (DHR)
Ionis Pharmaceuticals (IONS)
Celldex Therapeutics Com New (CLDX)
Bruker Corporation (BRKR)

View all positions for Eversept Partners

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
FMR
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Sands Capital Management
Rtw Investments
Baker Bros. Advisors
Suvretta Capital Management
Frontier Capital Management
Wellington Management Company
Bnp Paribas Investment Partners
Geode Capital Management
Jacobs Levy Equity Management
Standard Life Aberdeen

View all funds holding Ultragenyx Pharmaceutical